Ιατρικώς υποβοηθούμενη αναπαραγωγή και κίνδυνος για υπερτασικές διαταραχές στην κύηση: Μια σύντομη ανασκόπηση
More details
Hide details
Μαιευτική-Γυναικολογική Κλινική, Γενικό Νοσοκομείο Λαμίας, Λαμία, Ελλάδα
Μαιευτική και Γυναικολογική Κλινική-Τμήμα Ιατρικής, Σχολή Επιστημών Υγείας, Πανεπιστήμιο Θεσσαλίας, Πανεπιστημιακό Νοσοκομείο Λάρισας, Λάρισα, Ελλάδα
Submission date: 2023-09-22
Acceptance date: 2023-09-27
Publication date: 2023-09-30
Corresponding author
Ελένη Χρυσαφοπούλου   

Μαιευτική-Γυναικολογική Κλινική, Γενικό Νοσοκομείο Λαμίας, Λαμία, 35100, Ελλάδα
ΕΛΕΥΘΩ 2023;22(3):8
Pre-eclampsia's spectrum and prevalence in pregnancies resulting from assisted reproductive technologies (ART) have attempted to be correlated over the past few years. The purpose of the article is to descriptively review the literature on the connection between preeclampsia and medically assisted reproductive techniques. 16 articles were included in our minireview following a combined search through Pubmed. The majority of studies agree that, compared to pregnancies conceived naturally, IVF/ICSI singleton and multiple pregnancies are associated with a higher risk of hypertensive problems during pregnancy. Oocyte donor singleton pregnancies are more likely to result in hypertensive disorders in pregnancy. Also, frozen embryos have a higher chance of preeclampsia than fresh embryos. It is considered appropriate to develop clinical practice guidelines for women who have achieved pregnancy through ART techniques. Hence, women undergoing ART techniques should be informed of the increased risk of preeclampsia.
The authors have completed and submitted an ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
Almasi-Hashiani A, Omani-Samani R, Mohammadi M, et al. Assisted reproductive technology and the risk of preeclampsia: an updated systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019;19(1):149. doi:10.1186/s12884-019-2291-x
Chen XK, Wen SW, Bottomley J, Smith GN, Leader A, Walker MC. In vitro fertilization is associated with an increased risk for preeclampsia. Hypertens Pregnancy. 2009;28(1):1-12. doi:10.1080/10641950802001859
Chih HJ, Elias FTS, Gaudet L, Velez MP. Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses. BMC Pregnancy Childbirth. 2021;21(1):449. doi:10.1186/s12884-021-03938-8
Hernández-Díaz S, Werler MM, Mitchell AA. Gestational hypertension in pregnancies supported by infertility treatments: role of infertility, treatments, and multiple gestations. Fertil Steril. 2007;88(2):438-445. doi:10.1016/j.fertnstert.2006.11.131
Joy J, Armstrong L, Ardill J, Mcclure N, Cooke I. Biochemical markers of placental dysfunction in assisted conception. Hum Fertil (Camb). 2015;18(4):282-290. doi:10.3109/14647273.2015.1083620
Kenigsberg S, Bentov Y. Does contemporary ART lead to pre-eclampsia? A cohort study and meta-analysis. J Assist Reprod Genet. 2021;38(3):651-659. doi:10.1007/s10815-021-02061-z
Liu Z, Afink GB, Dijke PT. Soluble fms-like tyrosine kinase 1 and soluble endoglin are elevated circulating anti-angiogenic factors in pre-eclampsia. Pregnancy Hypertens. 2012;2(4):358-367. doi:10.1016/j.preghy.2012.06.003
Luke B, Brown MB, Eisenberg ML, et al. In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters. Am J Obstet Gynecol. 2020;222(4):350.e1-350.e13. doi:10.1016/j.ajog.2019.10.003
Miyake H, Iwasaki N, Nakai A, Suzuki S, Takeshita T. The influence of assisted reproductive technology on women with pregnancy-induced hypertension: a retrospective study at a Japanese Regional Perinatal Center. J Nippon Med Sch. 2010;77(6):312-317. doi:10.1272/jnms.77.312
Omani-Samani R, Alizadeh A, Almasi-Hashiani A, et al. Risk of preeclampsia following assisted reproductive technology: systematic review and meta-analysis of 72 cohort studies. J Matern Fetal Neonatal Med. 2020;33(16):2826-2840. doi:10.1080/14767058.2018.1560406
Opdahl S, Henningsen AA, Tiitinen A, et al. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod. 2015;30(7):1724-1731. doi:10.1093/humrep/dev090
Shevell T, Malone FD, Vidaver J, et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol. 2005;106(5 Pt 1):1039-1045. doi:10.1097/01.AOG.0000183593.24583.7c
Sun LM, Walker MC, Cao HL, Yang Q, Duan T, Kingdom JCP. Assisted reproductive technology and placenta-mediated adverse pregnancy outcomes. Obstet Gynecol. 2009;114(4):818-824. doi:10.1097/AOG.0b013e3181b76bd1
Thomopoulos C, Salamalekis G, Kintis K, et al. Risk of hypertensive disorders in pregnancy following assisted reproductive technology: overview and meta-analysis. J Clin Hypertens (Greenwich). 2017;19(2):173-183. doi:10.1111/jch.12945
Thomopoulos C, Tsioufis C, Michalopoulou H, Makris T, Papademetriou V, Stefanadis C. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. J Hum Hypertens. 2013;27(3):148-157. doi:10.1038/jhh.2012.13
Wang YA, Chughtai AA, Farquhar CM, Pollock W, Lui K, Sullivan EA. Increased incidence of gestational hypertension and preeclampsia after assisted reproductive technology treatment. Fertil Steril. 2016;105(4):920-926.e2. doi:10.1016/j.fertnstert.2015.12.024
Journals System - logo
Scroll to top